Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VAXCYTE, INC.

(PCVX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société VAXCYTE, INC.
01/13VAXCYTE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/13Vaxcyte Announces Pricing of $100 Million Public Offering
GL
01/13Vaxcyte Announces Pricing of $100 Million Public Offering
GL
01/12Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
AQ
01/06VAXCYTE : Investor Presentation January 2022
PU
01/06Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for ..
AQ
2021Vaxcyte to Present at Upcoming Investor Conferences
GL
2021Vaxcyte Investor Presentation November 2021
PU
2021Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update - For..
PU
2021Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
2021VAXCYTE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
2021VAXCYTE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
AQ
2021VAXCYTE : to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
AQ
2021VAXCYTE : to Present at 2021 Cantor Virtual Global Healthcare Conference
AQ
2021VAXCYTE : Investor Presentation September 2021
PU
2021VAXCYTE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
GL
2021VAXCYTE : Investor Presentation August 2021
PU
2021VAXCYTE : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form..
PU
2021VAXCYTE : Reports Second Quarter 2021 Financial Results and Provides Business Update
AQ
2021VAXCYTE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2021VAXCYTE : Announces Expanded CARB-X Award to Advance Development of VAX-A1, a Vaccine to P..
AQ
2021VAXCYTE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021Vaxcyte to Present at the Jefferies Virtual Healthcare Conference
GL
2021VAXCYTE : Investor Presentation May 2021
PU
2021Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
GL
2021VAXCYTE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2021VAXCYTE : Reports First Quarter 2021 Financial Results and Provides Business Update (Form ..
PU
2021VAXCYTE : Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for..
AQ
2021Vaxcyte to Present at BofA Securities 2021 Health Care Conference
GL
2021Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
GL
2021VAXCYTE : Investor Presentation March 2021
PU
2021Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Busine..
GL
2021VAXCYTE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2021VAXCYTE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
GL
2021VAXCYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial..
AQ
2021Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential..
GL
2020VAXCYTE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
GL
2020VAXCYTE : to Present at Evercore ISI 3rd Annual HealthCONx Conference
AQ
2020Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
GL
2020VAXCYTE : Reports Third Quarter 2020 Financial Results and Provides Business Update
AQ
2020Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
GL
2020VAXCYTE : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
2020VAXCYTE : to Present at Jefferies Virtual London Healthcare Conference
AQ
2020Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
GL
2020VAXCYTE : to Present at 2020 Cantor Virtual Global Healthcare Conference
AQ
2020Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
GL
2020CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides B..
GL
2020Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
GL
2020VAXCYTE, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Eve..
AQ
2020Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters'..
GL
Upcoming event on VAXCYTE, INC.
03/28/22